During the past decade, Biocerna LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Biocerna LLC" are "Alpha 1-Antitrypsin Deficiency" (1 trials) and "Subjects Possibly Exposed to COVID-19" (1 trials). Many other conditions were trialed in "Biocerna LLC" in a lesser frequency.

The vast majority of trials in "Biocerna LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Biocerna LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Biocerna LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Biocerna LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".